Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Juan F. Rivera
Advertisement
Articles by Juan F. Rivera
Advertisement
Latest Updated Articles
Pricing Turning Point: The Case for Innovating Pharma’s ModelPublished: March 6th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
Evolution of Biotech CFOs
5
